Skip to main content
Clinical Trials/NCT06032481
NCT06032481
Completed
Not Applicable

Preoperative Scoring System to Predict the Risk of Lymph Node Metastasis in Cervical Cancer

Fujian Maternity and Child Health Hospital0 sites426 target enrollmentJanuary 1, 2012
ConditionsCervical Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cervical Cancer
Sponsor
Fujian Maternity and Child Health Hospital
Enrollment
426
Primary Endpoint
Overall survival
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The lymph node status is difficult to be assessed preoperatively, this study aimed to develop a scoring system for predicting the risk of LNM in cervical cancer patients before operation.

Detailed Description

Lymph nodes metastasis (LNM) was proved to be a critical risk factor related to the survival to cervical cancer survival. However, preoperative pelvic magnetic resonance imaging (MR) or computed tomography (CT) tests are less sensitive to assess the risk of lymph node metastasis. PET-CT is too expensive and radiative to be widely used in clinical practice. A model was constructed based on clinical indicators to predict lymph node metastasis preoperatively, providing a reference for clinical treatment.

Registry
clinicaltrials.gov
Start Date
January 1, 2012
End Date
March 15, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Fujian Maternity and Child Health Hospital
Responsible Party
Principal Investigator
Principal Investigator

Yebin Feng

Director

Fujian Maternity and Child Health Hospital

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of cervical cancer
  • FIGO stage IB1-IIA1
  • Undergone radical hysterectomy with pelvic lymphadenectomy
  • Peformed pelvic MRI examination preoperatively

Exclusion Criteria

  • Had distant metastases diagnosed before or during the surgery
  • Underwent neoadjuvant radiotherapy preoperatively
  • Underwent neoadjuvant chemotherapy preoperatively
  • Incomplete or inaccuratemedical records

Outcomes

Primary Outcomes

Overall survival

Time Frame: 60 months

death or loss of follow-up

Secondary Outcomes

  • The accuracy of the model(60 months)
  • Risk factors influenced LNM(60 months)

Similar Trials